[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350717-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350717-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","longitudinally-cultured-precision-cut-lung-slices-as-a-predictive-ex-vivo-model-for-metastatic-lung-cancer","Longitudinally cultured precision cut lung slices as a predictive ex vivo model for metastatic lung cancer","","The research validates Precision Cut Lung Slices (PCLS) as a viable ex vivo platform for lung cancer studies. The work establishes prolonged viability and structural preservation needed for accurate drug response assessment. Paclitaxel serves as a benchmark and is tested alongside therapeutically promising silver nanoparticles combined with immunotherapy. Results show PCLS closely mimics in vivo responses with comparable tumor growth inhibition. The comparison supports reducing animal testing.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/longitudinally-cultured-precision-cut-lung-slices-as-a-predictive-ex-vivo-model-for-metastatic-lung-cancer/350717/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/longitudinally-cultured-precision-cut-lung-slices-as-a-predictive-ex-vivo-model-for-metastatic-lung-cancer/350717.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study regarding lung cancer models?","Question",{"text":63,"@type":64},"To explore alternatives to in vivo models by validating Precision Cut Lung Slices (PCLS) as a predictive ex vivo platform for metastatic lung cancer research.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PCLS assessed in the experimental design?",{"text":68,"@type":64},"The study used Paclitaxel as a benchmark drug and tested it alongside silver nanoparticles in combination with immunotherapy, comparing therapeutic effects on PCLS versus traditional in vivo models.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes support PCLS as a reliable alternative to in vivo testing?",{"text":72,"@type":64},"PCLS demonstrated prolonged viability and structural preservation, and it closely mimicked in vivo responses, showing comparable drug efficacy in tumor growth inhibition.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350717,1790763447,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","NANOMEDICINE  \n2026, VOL. 21, NO. 15, 2177–2193  \n[https://doi.org/10.1080/17435889.2026.2704651](https://doi.org/10.1080/17435889.2026.2704651)  \nRESEARCH ARTICLE     \nLongitudinally cultured precision cut lung slices as a predictive ex vivo model for metastatic lung cancer  \nAra Sargsian a, Hermon Girmatsion a, Vincent Lendersb, Ghesquière Bart c, Stefaan J. Soenen a,band Bella B. Manshian a,b  \naDepartment of Imaging and Pathology, NanoHealth and Optical Imaging Group, KU Leuven, Belgium; bDepartment of Imaging and Pathology, Translational Cell and Tissue Research Unit, KU Leuven, Belgium; cDepartment of Cellular and Molecular Medicine, Metabolomics Expertise Center, KU Leuven, Belgium  \nABSTRACT  \nAim: Exploring alternatives to in vivo models, this study validates Precision Cut Lung Slices (PCLS) asa viable ex vivo platform for lung cancer research. We established the prolonged viability and structural preservation of PCLS, essential for accurate drug response studies.  \nMaterial and methods: Using Paclitaxel as a benchmark drug and a therapeutically promising silver nanoparticles in combination with immunotherapy, we conducted a pioneering comparative analysis of its therapeutic effects on PCLS against traditional in vivo models.  \nResults: Revealed that PCLS closely mimics in vivo responses, demonstrating comparable drug efficacy in tumor growth inhibition.  \nConclusion: This direct comparison not only confirms the utility of PCLS in simulating real-world outcomes but also emphasizes its potential in reducing animal testing. By providing a reliable, ethical, and efficient alternative for lung cancer studies, PCLS could significantly enhance preclinical research and drug development, marking a critical step toward more humane and representative scientific investigations.  \nARTICLE HISTORY  \nReceived 23 February 2026 Accepted 13 July 2026  \nKEYWORDS  \nPrecision cut tissue slices; cancer models; ex vivo models; nanoparticles; personalized medicine  \n1. Introduction  \nThe development of reliable disease models is essential in biomedical research, yet many current systems do not fully reproduce the complexity of the in vivo environment. This limitation has driven the development of more physiologically relevant ex vivo models.  \n1.1. 3D cultures  \nOrganoids are self-organizing, three-dimensional in vitro models generated from pluripotent or adult stem cells that reproduce key aspects of native tissue architecture and function [1] . Organoids, although encompassing various cell types found in patient tissues, fall short of replicating the spatial distribution and complex cell–cell and cell–matrix interactions present in the native tumor microenvironment [2,3] . While they provide better approximation of tissue architecture and cellular interactions, their dependence on artificial matrices and stem-cell differentiation can introduce variability [4] . Moreover, these systems often lack the complete cellular diversity and complexity of native tissue, and lack the interindividual heterogeneity in tissue composition and architecture, whether healthy or diseased [5,6] . Addressing these issues requires advanced co-culture systems and 3D culture techniques that incorporate multiple cell types and better mimic the in vivo environment to improve physiological relevance and reproducibility.  \n1.2. Bridging the gap: precision-cut tissue slices (PCTS)  \nPrecision-cut tissue slices are uniform, live tissue sections from human or animal organs that preserve the native tissue’s architecture, function, and cellular complexity. One of the distinguishing features of PCTS lies in its ability to preserve the spatial distribution of different cell populations within the native tissue [2]. Because of these features, they serve as valuable ex vivo models for respiratory disease, infection, drug screening, immunotherapy, and treatment-response studies [2,7–13].  \nPCTS also align with the 3Rs (Refinement, Reduction, and Replacement) principle by reduc","cbCaipsBFiHQLcZP","https://ap.wps.com/l/cbCaipsBFiHQLcZP","pdf",12611840,17,"English","# 1. Introduction\n## 1.1. 3D cultures\n## 1.2. Bridging the gap: precision-cut tissue slices (PCTS)","[{\"question\":\"What is the main goal of the study regarding lung cancer models?\",\"answer\":\"To explore alternatives to in vivo models by validating Precision Cut Lung Slices (PCLS) as a predictive ex vivo platform for metastatic lung cancer research.\"},{\"question\":\"How was PCLS assessed in the experimental design?\",\"answer\":\"The study used Paclitaxel as a benchmark drug and tested it alongside silver nanoparticles in combination with immunotherapy, comparing therapeutic effects on PCLS versus traditional in vivo models.\"},{\"question\":\"What outcomes support PCLS as a reliable alternative to in vivo testing?\",\"answer\":\"PCLS demonstrated prolonged viability and structural preservation, and it closely mimicked in vivo responses, showing comparable drug efficacy in tumor growth inhibition.\"}]","Longitudinally cultured precision cut lung slices as a predictive ex vivo model for metastatic lung cancer | PDF",1790090754,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aec982f26ae6bc0dc58389ecb1228af5.webp",983,1280,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69883a2d3f0ed83d4ff6d768073fda6f.webp",982,1278,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd29cad589ac20d20b17dbb308bf4d9c.webp",981,1277,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c69cf1eedd68a5e6de787e9e60c9b1e7.webp",980,1276]